Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Shandong Weigao Blood Purification Products Co. Ltd. (603014)
Market Closed
16 Oct, 06:56 AM
SSE
All
(1)
CN
(1)
SSE
Primary
¥
29.
06
-0.21
-0.7175%
¥
14.75B
Market Cap
-
P/E Ratio
0.16%
Div Yield
941,650
Volume
-
Eps
¥
29.27
Previous Close
Watching
Watch
Add Transaction
Day Range
28.85
29.75
Year Range
28.85
49.01
Want to track
603014
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Shandong Weigao Blood Purification Products Co. Ltd. (603014) Statistics
Valuation metrics
Market Cap
14.75B
Enterprise value
12.22B
Trailing P/E (ttm)
29.63
Forward P/E
26.94
PEG ratio
26.94
Price/Sales (ttm)
3.94
Price/Book (mrq)
2.09
Enterprise Value/Revenue
3.24
Enterprise Value/EBITDA
15.61
Overview
Shares outstanding
417.75M
Float
65.16M
Shares short
-
% Held by insiders
0.79%
% Held by institutions
0.04%
Average volume (10 days)
952.83K
Average volume (90 days)
885.84K
Price summary
52-Week low
28.85
52-Week high
49.01
Beta
-
50-Day moving average
37.16
200-Day moving average
39.59
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.13%
Operating margin
0.15%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.08%
Income Statement
Revenue (ttm)
3.77B
Revenue per share (ttm)
9.53
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
1.51B
EBITDA
570.9M
Net income to common (ttm)
482.3M
Diluted EPS (ttm)
1.2
Quarterly earnings growth (yoy)
0.06%
Balance Sheet
Total cash (mrq)
2.81B
Total cash per share (mrq)
6.71
Total debt (mrq)
2.93M
Total Debt/Equity (mrq)
0.04
Current ratio (mrq)
3.3%
Book value per share (mrq)
17.04
Cash Flow
Cash flow statement
793.71M
Levered free cash flow (LFCF)
500.49M